Praxis Precision Medicines, Inc.
PRAX
$37.20
$0.792.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.46M | 302.00K | 357.00K | 431.00K | 515.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.46M | 302.00K | 357.00K | 431.00K | 515.00K |
| Cost of Revenue | 56.29M | 41.88M | 27.26M | 26.98M | 18.39M |
| Gross Profit | -48.83M | -41.58M | -26.90M | -26.55M | -17.87M |
| SG&A Expenses | 15.13M | 15.26M | 10.59M | 15.33M | 9.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 71.42M | 57.14M | 37.85M | 42.32M | 28.32M |
| Operating Income | -63.96M | -56.84M | -37.49M | -41.89M | -27.81M |
| Income Before Tax | -58.68M | -51.91M | -32.68M | -39.55M | -26.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.68M | -51.91M | -32.68M | -39.55M | -26.88M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.68M | -51.91M | -32.68M | -39.55M | -26.88M |
| EBIT | -63.96M | -56.84M | -37.49M | -41.89M | -27.81M |
| EBITDA | -63.91M | -56.74M | -37.38M | -41.77M | -27.70M |
| EPS Basic | -2.94 | -2.75 | -1.74 | -2.84 | -2.97 |
| Normalized Basic EPS | -1.88 | -1.72 | -1.08 | -1.78 | -1.85 |
| EPS Diluted | -2.94 | -2.75 | -1.74 | -2.84 | -2.97 |
| Normalized Diluted EPS | -1.88 | -1.72 | -1.08 | -1.78 | -1.85 |
| Average Basic Shares Outstanding | 19.98M | 18.88M | 18.82M | 13.90M | 9.06M |
| Average Diluted Shares Outstanding | 19.98M | 18.88M | 18.82M | 13.90M | 9.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |